ITCA-650

Intarcia vs. Novo: Which has the most appealing diabetes PhIII program?
Fierce Pharma
Fri, 08/28/15 - 05:44 pm
Novo Nordisk
Intarcia
diabetes
ITCA-650
Merck
Januvia
semaglutide